Paul Talla

Factors Associated with Treatment Failure for Hepatitis C in the Era of Direct-Acting Antivirals Therapy in Cameroon

M. Kowo, F. Andoulo, M. T. Sartre, 2020 .

Achieving a high cure rate with direct‐acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi‐clinic demonstration project

L. Coyer, R. Njouom, P. Ondoa, 2020, Tropical medicine & international health : TM & IH.

Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon

M. Kowo, D. Noah, F. Andoulo, 2014, The Pan African medical journal.

Acute Coronary Syndrome Occurring in a Sub-Saharan Patient Treated with a Reduced Dose of Sorafenib for an Unresectable Hepatocellular Carcinoma: Case Report

J. Boombhi, A. Ménanga, F. Andoulo, 2020, Open Journal of Gastroenterology.

Involvement of CD95 and ligand in CD4+ T-cell and CD8+ T-cell depletion and hepatic cytolysis in patients with chronic viral hepatitis B

G. Ikomey, G. B. Jacobs, Elise Guiedem, 2021, African journal of laboratory medicine.

Diagnostic Performance of Faecal Calprotectin among People with Chronic Inflammatory Diseases of the Bowel in Cameroon: A Pilot Study in Sub-Saharan Africa

V. Moor, B. Agoons, Paul Talla, 2021, International Journal of Biochemistry Research & Review.

Epidemiology of Hepatitis B-Associated Hepatocellular Carcinoma in Cameroon

M. Kowo, F. Andoulo, R. Djapa, 2013 .

Aetiology and risk factors of acute upper gastrointestinal hemorrhage: analysis of 613 cases in Yaounde, Cameroon

M. Kowo, F. Andoulo, E. C. Ndam, 2013 .

Endoscopic mucosal phenotypes and endoscopic Sydney system gastritis assessment in relation to Helicobacter pylori infection and upper digestive clinical signs: A 2‐year study among patients with gastroduodenal disorders in Cameroon

L. B. Kouitcheu Mabeku, Paul Talla, D. Paul, 2024, JGH open : an open access journal of gastroenterology and hepatology.